1. Home
  2. NBIX vs ALB Comparison

NBIX vs ALB Comparison

Compare NBIX & ALB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

N/A

Current Price

$155.12

Market Cap

15.5B

Sector

Health Care

ML Signal

N/A

Logo Albemarle Corporation

ALB

Albemarle Corporation

N/A

Current Price

$126.75

Market Cap

15.8B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
NBIX
ALB
Founded
1992
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
15.5B
15.8B
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
NBIX
ALB
Price
$155.12
$126.75
Analyst Decision
Strong Buy
Buy
Analyst Count
22
20
Target Price
$180.91
$179.74
AVG Volume (30 Days)
1.1M
2.0M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
0.85%
EPS Growth
41.95
48.57
EPS
3.30
5.87
Revenue
$161,626,000.00
$5,142,733,000.00
Revenue This Year
$24.73
$12.12
Revenue Next Year
$13.14
$5.74
P/E Ratio
$47.95
$22.89
Revenue Growth
977.51
N/A
52 Week Low
$122.14
$71.25
52 Week High
$186.12
$221.00

Technical Indicators

Market Signals
Indicator
NBIX
ALB
Relative Strength Index (RSI) 48.44 51.88
Support Level $153.96 $131.00
Resistance Level $161.29 $144.06
Average True Range (ATR) 3.58 4.60
MACD 0.90 0.09
Stochastic Oscillator 77.56 31.93

Price Performance

Historical Comparison
NBIX
ALB

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About ALB Albemarle Corporation

Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.

Share on Social Networks: